A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J.

Open source

DOI: 10.1093/jac/dkaf389
Published: 2025-12-01
Container: J Antimicrob Chemother
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkaf389,
  title = {A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).},
  author = {Buzón-Martín L and  Montes ML and  Pedrero R and  Galindo MJ and  Santacreu-Guerrero M and  Alemán MR and  Torralba M and  Díaz de Santiago A and  Fanjul F and  Rodríguez A and  Cabello A and  Crusells MJ and  Navarro MDC and  Aguilera M and  Hidalgo-Tenorio C and  Morano-Amado LE and  Vinuesa D and  De Andres C and  Bernal-Morell E and  Martínez-Álvarez RM and  Cabello-Clotet N and  Tiraboschi J and  Montero MDC and  Vivancos-Gallego MJ and  Díez C and  Calderón R and  De Zárraga MA and  Gisbert L and  Romero-Palacios A and  Cabo R and  Soler JF and  Sepúlveda MA and  Sánchez-Guirao AJ and  Escrich C and  Arnaiz De Las Revillas F and  Ferreira E and  Valentín B and  Lérida A and  Llenas-García J and  Gómez A and  Losa JE and  Alonso B and  Sanz J and  Masiá M and  Pernas H and  Corte JJ and  Garcinuño MÁ and  Gainzarain JC and  Estébanez M and  García-Navarro MDM and  Barragán P and  Ramos N and  Clavero M and  Millán M and  Del Álamo M and  Egido M and  De La Calle B and  Ferrero OL and  Troya J.},
  year = {2025},
  journal = {J Antimicrob Chemother},
  doi = {10.1093/jac/dkaf389},
  url = {https://doi.org/10.1093/jac/dkaf389}
}

RIS

TY  - JOUR
TI  - A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).
AU  - Buzón-Martín L
AU  -  Montes ML
AU  -  Pedrero R
AU  -  Galindo MJ
AU  -  Santacreu-Guerrero M
AU  -  Alemán MR
AU  -  Torralba M
AU  -  Díaz de Santiago A
AU  -  Fanjul F
AU  -  Rodríguez A
AU  -  Cabello A
AU  -  Crusells MJ
AU  -  Navarro MDC
AU  -  Aguilera M
AU  -  Hidalgo-Tenorio C
AU  -  Morano-Amado LE
AU  -  Vinuesa D
AU  -  De Andres C
AU  -  Bernal-Morell E
AU  -  Martínez-Álvarez RM
AU  -  Cabello-Clotet N
AU  -  Tiraboschi J
AU  -  Montero MDC
AU  -  Vivancos-Gallego MJ
AU  -  Díez C
AU  -  Calderón R
AU  -  De Zárraga MA
AU  -  Gisbert L
AU  -  Romero-Palacios A
AU  -  Cabo R
AU  -  Soler JF
AU  -  Sepúlveda MA
AU  -  Sánchez-Guirao AJ
AU  -  Escrich C
AU  -  Arnaiz De Las Revillas F
AU  -  Ferreira E
AU  -  Valentín B
AU  -  Lérida A
AU  -  Llenas-García J
AU  -  Gómez A
AU  -  Losa JE
AU  -  Alonso B
AU  -  Sanz J
AU  -  Masiá M
AU  -  Pernas H
AU  -  Corte JJ
AU  -  Garcinuño MÁ
AU  -  Gainzarain JC
AU  -  Estébanez M
AU  -  García-Navarro MDM
AU  -  Barragán P
AU  -  Ramos N
AU  -  Clavero M
AU  -  Millán M
AU  -  Del Álamo M
AU  -  Egido M
AU  -  De La Calle B
AU  -  Ferrero OL
AU  -  Troya J.
PY  - 2025
JO  - J Antimicrob Chemother
DO  - 10.1093/jac/dkaf389
UR  - https://doi.org/10.1093/jac/dkaf389
ER  -

APA

L, B., ML, M., R, P., MJ, G., M, S., MR, A., M, T., A, D. D. S., F, F., A, R., A, C., MJ, C., MDC, N., M, A., C, H., LE, M., D, V., C, D. A., E, B., RM, M., N, C., J, T., MDC, M., MJ, V., C, D., R, C., MA, D. Z., L, G., A, R., R, C., JF, S., MA, S., AJ, S., C, E., F, A. D. L. R., E, F., B, V., A, L., J, L., A, G., JE, L., B, A., J, S., M, M., H, P., JJ, C., MÁ, G., JC, G., M, E., MDM, G., P, B., N, R., M, C., M, M., M, D. Á., M, E., B, D. L. C., OL, F., & J., T. (2025). A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkaf389

Source records

europe-pmc · retrieved 2026-09-26T01:12:44.225Z